Effexor
Product Images NDC 0008-0837

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Effexor (NDC 0008-0837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Effexorxr 01)

FDA Label Image

Figure 2 (Effexorxr 02)

FDA Label Image

Figure 3 (Effexorxr 03)

FDA Label Image

Chemical Structure (Effexorxr 04)

FDA Label Image

Logo (Effexorxr 05)

This is a description of the distributor of a pharmaceutical product. The company is Wyeth Pharmaceuticals LLC, which is a subsidiary of Pfizer Inc, based in Philadelphia, PA 19101.*

FDA Label Image

Logo (Effexorxr 05a)

This is a description of a company called Wyeth Pharmaceuticals LLC, which is a subsidiary of Pfizer Inc. The text suggests that this company is involved in the distribution of products or services.*

FDA Label Image

Principal Display Panel (37.5 mg Capsule Bottle Label)

This is a description of medication called Effexor XR, manufactured in Switzerland and distributed by Wyeth Pharmaceuticals. Each capsule contains Venlafaxine HOI ingredient weighing 1037.5mg. The medication is to be dispensed in accordance with the accompanying dosage instructions. The controlled room temperature for storage of the medication is between 20°to 25°C. The packaging is to be dispensed as a unit and a medication guide should accompany each prescription. The details of dosage can be found in the prescribing information that accompanies the medication. The has provided information regarding Lot and Exp numbers, and packaging details as well.*

FDA Label Image

Principal Display Panel (37.5 mg Capsule Blister Pack)

This is a label with information about a medication called Effexor XR (venlafaxine HCI) in extended-release capsules that contain 37.5mg of the active ingredient. The label includes information about the manufacturer (Wyeth Pharmaceuticals Inc., Philadelphia) and the product code (10161 Vd E1Md YR AN). The rest of the text is not legible.*

FDA Label Image

Principal Display Panel (37.5 mg Capsule Blister Pack Carton)

FDA Label Image

Principal Display Panel (75 mg Capsule Bottle Label)

This is a prescription medication called Effexor XR® that comes in a package with 30 extended-release capsules containing venlafaxine HCI equivalent to 75 mg venlafaxine. It is intended to be dispensed with a medication guide and the usual dosage is specified on the prescription information that comes with it. The medication should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F). It is distributed by Wyeth Pharmaceuticals LLG, a subsidiary of Pfizer Inc. made in Switzerland. The product is identified by its NDC code 0008-0833-21.*

FDA Label Image

Principal Display Panel (75 mg Capsule Blister Pack)

This is a prescription information leaflet for the medication Effexor XR (extended-release capsules) containing 75mg of Venlafaxine HCl, a type of antidepressant. The leaflet includes the manufacturer's details, dosage instructions, and warnings.*

FDA Label Image

Principal Display Panel (75 mg Capsule Blister Pack Carton)

Effexor XR is a medication available in a package of 100 extended-release capsules of venlafaxine HCI. The capsules are contained in 10 Redipak blister strips, each strip has ten capsules. The medication guide is always dispensed together with the drug. The package is not meant for household use and should be stored in a controlled room temperature of 20°C to 25°C. The usual dosage for this medicine is indicated in the prescribing information.*

FDA Label Image

Principal Display Panel (150 mg Capsule Bottle Label)

Effexor XR (venlafaxine HCI) Extended-Release Capsules are intended to be dispensed as a unit where each capsule contains 150 mg of venlafaxine HCI. The usual dosage should be seen in the accompanying prescribing information. The capsules should be stored at a controlled room temperature of 25°C (77°F) - 30°C (86°F). They are manufactured in Switzerland and distributed by Wyeth Pharmaceuticals LLC, which is a subsidiary of Prizer Inc, located in Philadelphia. The medication guide is always dispensed with the capsules. No non-English characters were detected.*

FDA Label Image

Principal Display Panel (150 mg Capsule Blister Pack)

This appears to be a collection of partially decipherable codes, letters, numbers, and pharmaceutical product names. Without further context, it is not possible to provide a description or explanation of the significance of the text.*

FDA Label Image

Principal Display Panel (150 mg Capsule Blister Pack Carton)

Effexor XR is a medication that comes in a package that contains 100 capsules in 10 Redipak blister strips, each with 10 capsules. It is an extended-release capsule of venlafaxine HCI, with a dosage of up to 150mg. It is manufactured in Switzerland and distributed by Wyeth Pharmaceuticals, a subsidiary of Pfizer Inc. It is recommended to store the medication at room temperature and use it with a medication guide. Further dosage information can be found in the prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.